Atlas Trials

Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections

Clinical trial NCT01726023 · COMPLETED

Trial details

NCT number
NCT01726023
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Complicated Intra-abdominal Infection
Start date
2013-01-01
Primary completion
2015-03-01
Enrollment
486

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.